Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market 2018-2022

Publisher Name :
Date: 22-Mar-2018
No. of pages: 116
Inquire Before Buying

About Post-Traumatic Stress Disorder (PTSD) Therapeutics

PTSD) therapeutics include drugs that are used in the treatment of PTSD.

The analysts forecast global post-traumatic stress disorder (PTSD) therapeutics market to grow at a CAGR of 1.26% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global post-traumatic stress disorder (PTSD) therapeutics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of post-traumatic stress disorder (PTSD) therapeutics.

The market is divided into the following segments based on geography:

- Americas

- APAC

- EMEA

The report, Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

- GlaxoSmithKline

- Pfizer

- Eli Lilly and Company

- H. Lundbeck

Market driver

- Increasing initiatives by public and private organizations

- For a full, detailed list, view our report

Market challenge

- Unmet need for existing therapies

- For a full, detailed list, view our report

Market trend

- Emerging therapies for PTSD treatment

- For a full, detailed list, view our report

Key questions answered in this report

- What will the market size be in 2022 and what will the growth rate be?

- What are the key market trends?

- What is driving this market?

- What are the challenges to market growth?

- Who are the key vendors in this market space?

Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market 2018-2022

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis

PART 05: PIPELINE LANDSCAPE

PART 06: MARKET SIZING
Market definition
Market sizing 2017
Market size and forecast 2017-2022

PART 07: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

PART 08: MARKET SEGMENTATION BY PRODUCT
Segmentation by product
Comparison by product
Antidepressants
Anxiolytics
Other PTSD therapeutics
Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE
Geographical segmentation
Regional comparison
PTSD therapeutics market in Americas
PTSD therapeutics market in EMEA
PTSD therapeutics market in APAC
Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
Market drivers
Market challenges

PART 13: MARKET TRENDS
Emerging therapies for PTSD treatment
Increasing focus on clinical research by pharmaceutical companies and institutions

PART 14: VENDOR LANDSCAPE
Overview
Landscape disruption

PART 15: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
GlaxoSmithKline
Pfizer
Eli Lilly and Company
H. Lundbeck

PART 16: APPENDIX
List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global CNS disorders therapeutics market segmentation
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Major pipeline products
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2017
Exhibit 08: Validation techniques employed for market sizing 2017
Exhibit 09: Global PTSD therapeutics market - Market size and forecast 2017-2022 ($ mn)
Exhibit 10: Global PTSD therapeutics market - Year-over-year growth 2018-2022 (%)
Exhibit 11: Five forces analysis 2017
Exhibit 12: Five forces analysis 2022
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition - Five forces 2017
Exhibit 19: Global PTSD therapeutics market - Market share 2017-2022 (%)
Exhibit 20: Comparison by product
Exhibit 21: Antidepressants market - Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Antidepressants market - Year-over-year growth 2018-2022 (%)
Exhibit 23: Anxiolytics market - Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Anxiolytics market - Year-over-year growth 2018-2022 (%)
Exhibit 25: Other PTSD therapeutics - Market size and forecast 2017-2022 ($ mn)
Exhibit 26: Other PTSD therapeutics - Year-over-year growth 2018-2022 (%)
Exhibit 27: Market opportunity by product
Exhibit 28: Customer landscape
Exhibit 29: Global PTSD therapeutics market - Market share by geography 2017-2022 (%)
Exhibit 30: Regional comparison
Exhibit 31: PTSD therapeutics market in Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 32: PTSD therapeutics market in Americas - Year-over-year growth 2018-2022 (%)
Exhibit 33: Top 3 countries in Americas
Exhibit 34: PTSD therapeutics market in EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 35: PTSD therapeutics market in EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 36: Top 3 countries in EMEA
Exhibit 37: PTSD therapeutics market in APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 38: PTSD therapeutics market in APAC - Year-over-year growth 2018-2022 (%)
Exhibit 39: Top 3 countries in APAC
Exhibit 40: Market opportunity
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: GlaxoSmithKline - Overview
Exhibit 47: GlaxoSmithKline - Business segments
Exhibit 48: GlaxoSmithKline - Organizational developments
Exhibit 49: GlaxoSmithKline - Geographic focus
Exhibit 50: GlaxoSmithKline - Segment focus
Exhibit 51: GlaxoSmithKline - Key offerings
Exhibit 52: GlaxoSmithKline - Key customers
Exhibit 53: Pfizer - Overview
Exhibit 54: Pfizer - Business segments
Exhibit 55: Pfizer - Organizational developments
Exhibit 56: Pfizer - Geographic focus
Exhibit 57: Pfizer - Segment focus
Exhibit 58: Pfizer - Key offerings
Exhibit 59: Pfizer - Key customers
Exhibit 60: Eli Lilly and Company - Overview
Exhibit 61: Eli Lilly and Company - Business segments
Exhibit 62: Eli Lilly and Company - Organizational developments
Exhibit 63: Eli Lilly and Company - Geographic focus
Exhibit 64: Eli Lilly and Company - Segment focus
Exhibit 65: Eli Lilly and Company - Key offerings
Exhibit 66: Eli Lilly and Company - Key customers
Exhibit 67: H. Lundbeck - Overview
Exhibit 68: H. Lundbeck - Business segments
Exhibit 69: H. Lundbeck - Organizational developments
Exhibit 70: H. Lundbeck - Geographic focus
Exhibit 71: H. Lundbeck - Segment focus
Exhibit 72: H. Lundbeck - Key offerings
Exhibit 73: H. Lundbeck - Key customers
  • Global and United States Virus Like Particles Market Research by Company, Type & Application 2013-2025
    Published: 14-Oct-2018        Price: US 2000 Onwards        Pages: 117
    Summary Market Segment as follows: By Type - Adeno-Associated Virus - HIV - Hepatitis B Virus - Hepatitis C Virus - Others By Application - Vaccines - Mycoviruses - Virus Research - Therapeutic and Imaging Agents - Others By Company - GlaxoSmithKline - Merck - Novavax - Takeda - Medicago - MedImmune - TechnoVax ......
  • Global Enzyme Replacement Therapy Market Size, Status and Forecast 2018-2025
    Published: 09-Oct-2018        Price: US 3900 Onwards        Pages: 91
    This report focuses on the global Enzyme Replacement Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Enzyme Replacement Therapy development in United States, Europe and China. Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.......
  • Global Infantile Spasms Therapeutics Market Insights, Forecast to 2025
    Published: 09-Oct-2018        Price: US 3900 Onwards        Pages: 119
    This report studies the global market size of Infantile Spasms Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Infantile Spasms Therapeutics in these regions. This research report categorizes the global Infantile Spasms Therapeutics market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, f......
  • Global Gout Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 09-Oct-2018        Price: US 3480 Onwards        Pages: 135
    Gout is a physical conditions that affects the patient's ability to move, often also termed as unwalkable disease, and it has been around for centuries. Scope of the Report: This report studies the Gout Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gout Therapeutics market by product type and applications/en......
  • Global Peptide Therapeutics Market Insights, Forecast to 2025
    Published: 04-Oct-2018        Price: US 3900 Onwards        Pages: 122
    This report studies the global market size of Peptide Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Peptide Therapeutics in these regions. This research report categorizes the global Peptide Therapeutics market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market driver......
  • Global Microbiome Therapeutics Market Insights, Forecast to 2025
    Published: 03-Oct-2018        Price: US 3900 Onwards        Pages: 126
    This report studies the global market size of Microbiome Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Microbiome Therapeutics in these regions. This research report categorizes the global Microbiome Therapeutics market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, mark......
  • Global Human Microbiome Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 03-Oct-2018        Price: US 3480 Onwards        Pages: 117
    Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Microbiome therapeutics are therapies that are designed to disrupt unhealthy microbial ecological networks and that catalyse the establishment of healthy ones. Scope of the Report: ......
  • Global Hormone Replacement Therapy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 03-Oct-2018        Price: US 3480 Onwards        Pages: 136
    Hormone replacement therapy refers to the treatment of the patients with growth hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low. Scope of the Report: This report studies the Hormone Replacement Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top ......
  • Global Microbiome Partnering 2012-2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 126
    The Global Microbiome Partnering Terms and Agreements 2010 to 2018 report provides comprehensive understanding and unprecedented access to the Microbiome partnering deals and agreements entered into by the worlds leading healthcare companies The Global Microbiome Partnering Terms and Agreements 2010 to 2018 report provides an understanding and access to the Microbiome partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Microbio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs